Loeb Partners Corp’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-8,700
Closed -$1.16M 323
2018
Q4
$1.16M Buy
8,700
+5,000
+135% +$820K 0.54% 51
2018
Q3
$705K Sell
3,700
-7,130
-66% -$1.31M 0.26% 80
2018
Q2
$1.81M Buy
10,830
+4,630
+75% +$743K 0.46% 64
2018
Q1
$1.04M Buy
+6,200
New +$1.04M 0.45% 57
2017
Q2
Sell
-1,000
Closed -$239K 181
2017
Q1
$239K Hold
1,000
0.07% 150
2016
Q4
$210K Buy
+1,000
New +$207K 0.07% 146
2015
Q2
Sell
-4,000
Closed -$1.19M 202
2015
Q1
$1.19M Buy
+4,000
New +$1.14M 0.35% 76

Other funds holding AGN

Loeb Partners Corp's AGN Position: Q1 2019 in Review

Loeb Partners Corp sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 8,700 shares — an estimated $1.16M sold.

Loeb Partners Corp first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $1.81M in Q2 2018. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Loeb Partners Corp reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Loeb Partners Corp sold 8,700 Allergan plc shares in Q1 2019, an estimated $1.16M.
  • Loeb Partners Corp first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Loeb Partners Corp's Allergan plc position peaked at $1.81M in Q2 2018.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Loeb Partners Corp's 13F filing for Q1 2019, filed 14 May 2019.